BioCentury | Aug 1, 2020
Management Tracks

Nabel leaves Moderna’s board to avoid conflict-of-interest concerns; plus changes at Genespire, La Jolla, Editas and more

...CMO. He was VP of clinical development at Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY). Genomic diagnostics company Veracyte Inc....
...EVP and general counsel. Previously, he held the same position at IQVia Holdings Inc. (NYSE:IQV). Veracyte...
...to predict clinical outcomes. Robin Sawka, BioCentury Staff Moderna Inc. Genespire Inc. La Jolla Pharmaceutical Co. Editas Medicine Inc. Arcutis Biotherapeutics Inc. Veracyte Inc. Merus...
BioCentury | Jul 13, 2019
Finance

How crossover, insider support and big money correlated with performance across 1H19 IPOs

...NASDAQ:ICPT) 5/10/19 $230.5 $2,726.8 $2,598.5 -5% Twist Bioscience Corp. (NASDAQ:TWST) 5/8/19 $90.6 $679.1 $938.1 38% Veracyte Inc....
BioCentury | Jul 1, 2019
Company News

Management Tracks: BioCryst hires its first CBO; plus ObsEva, Veracyte and more

...drug safety and pharmacovigilance. Garner was CMO, SVP clinical development at Agile Therapeutics Inc. (NASDAQ:AGRX). Veracyte Inc....
... Mary Romeo, Assistant Editor Axovant Gene Therapies Ltd. BioCryst Pharmaceuticals Inc. Nanobiotix S.A. National Cancer Institute ObsEva S.A. Squarex LLC Terns Pharmaceuticals Inc. Veracyte Inc. Viela...
BioCentury | Jul 27, 2018
Financial News

Veracyte raises $51.3M follow-on

...Molecular diagnostics company Veracyte Inc. (NASDAQ:VCYT) raised $51.3 million on July 25 through the sale of 5...
...a follow-on underwritten by Leerink, William Blair and BTIG. Veracyte Inc. (NASDAQ:VCYT), South San Francisco, Calif. Alicia Parker Veracyte Inc....
BioCentury | Apr 13, 2018
Company News

Veracyte, Loxo team up for TRK, RET targeted therapies

...Molecular diagnostics company Veracyte Inc. (NASDAQ:VCYT) said Loxo Oncology Inc. (NASDAQ:LOXO) will use Veracyte's Afirma Xpression Atlas...
...deal terms were not disclosed. The RNA sequencing-based Afirma Xpression Atlas is an extension of Veracyte's...
...non-small cell lung cancer (NSCLC) and solid tumors as well as thyroid and colon cancer. Veracyte Inc....
BioCentury | Jun 2, 2017
Company News

Anthem to cover Veracyte's Afirma test for detecting thyroid cancer

...a preoperative molecular diagnostic classifier based on genomic measurements from fine needle aspirate (FNA) samples. Veracyte Inc....
...South San Francisco, Calif. Anthem Inc. (NYSE:ANTM), Indianapolis, Ind. Business: Diagnostic Shannon Lehnbeuter Afirma Gene Expression Classifier Anthem Inc. Veracyte Inc....
BioCentury | Mar 2, 2017
Company News

Management tracks

...of Chelsea Therapeutics International Ltd. , which H. Lundbeck A/S (CSE:LUN) acquired. Genomic diagnostics company Veracyte Inc....
BioCentury | Jan 6, 2017
Finance

Good riddance

...NYSE-M:SYN) (A) 11/15/16 $25.0 NA $89.1 NA Tesaro Inc. (NASDAQ:TSRO) 11/15/16 $236.3 $7,210.7 $7,182.9 0% Veracyte Inc....
BioCentury | Nov 4, 2016
Financial News

Veracyte completes follow-on

...in a follow-on underwritten by Leerink Partners and BTIG. Veracyte Inc. (NASDAQ:VCYT), South San Francisco, Calif. Alicia Parker Veracyte Inc....
BioCentury | Nov 2, 2016
Financial News

Veracyte raises $30M in follow-on

...Molecular diagnostics company Veracyte Inc. (NASDAQ:VCYT) raised $30 million through the sale of 5 million shares at...
...in a follow-on underwritten by Leerink and BTIG. The price is a 16% discount to Veracyte's...
...a diagnostic tool for idiopathic pulmonary fibrosis (IPF). Veracyte fell $0.73 to $6.40 on Wednesday. Chris Lieu Veracyte Inc....
Items per page:
1 - 10 of 53
BioCentury | Aug 1, 2020
Management Tracks

Nabel leaves Moderna’s board to avoid conflict-of-interest concerns; plus changes at Genespire, La Jolla, Editas and more

...CMO. He was VP of clinical development at Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY). Genomic diagnostics company Veracyte Inc....
...EVP and general counsel. Previously, he held the same position at IQVia Holdings Inc. (NYSE:IQV). Veracyte...
...to predict clinical outcomes. Robin Sawka, BioCentury Staff Moderna Inc. Genespire Inc. La Jolla Pharmaceutical Co. Editas Medicine Inc. Arcutis Biotherapeutics Inc. Veracyte Inc. Merus...
BioCentury | Jul 13, 2019
Finance

How crossover, insider support and big money correlated with performance across 1H19 IPOs

...NASDAQ:ICPT) 5/10/19 $230.5 $2,726.8 $2,598.5 -5% Twist Bioscience Corp. (NASDAQ:TWST) 5/8/19 $90.6 $679.1 $938.1 38% Veracyte Inc....
BioCentury | Jul 1, 2019
Company News

Management Tracks: BioCryst hires its first CBO; plus ObsEva, Veracyte and more

...drug safety and pharmacovigilance. Garner was CMO, SVP clinical development at Agile Therapeutics Inc. (NASDAQ:AGRX). Veracyte Inc....
... Mary Romeo, Assistant Editor Axovant Gene Therapies Ltd. BioCryst Pharmaceuticals Inc. Nanobiotix S.A. National Cancer Institute ObsEva S.A. Squarex LLC Terns Pharmaceuticals Inc. Veracyte Inc. Viela...
BioCentury | Jul 27, 2018
Financial News

Veracyte raises $51.3M follow-on

...Molecular diagnostics company Veracyte Inc. (NASDAQ:VCYT) raised $51.3 million on July 25 through the sale of 5...
...a follow-on underwritten by Leerink, William Blair and BTIG. Veracyte Inc. (NASDAQ:VCYT), South San Francisco, Calif. Alicia Parker Veracyte Inc....
BioCentury | Apr 13, 2018
Company News

Veracyte, Loxo team up for TRK, RET targeted therapies

...Molecular diagnostics company Veracyte Inc. (NASDAQ:VCYT) said Loxo Oncology Inc. (NASDAQ:LOXO) will use Veracyte's Afirma Xpression Atlas...
...deal terms were not disclosed. The RNA sequencing-based Afirma Xpression Atlas is an extension of Veracyte's...
...non-small cell lung cancer (NSCLC) and solid tumors as well as thyroid and colon cancer. Veracyte Inc....
BioCentury | Jun 2, 2017
Company News

Anthem to cover Veracyte's Afirma test for detecting thyroid cancer

...a preoperative molecular diagnostic classifier based on genomic measurements from fine needle aspirate (FNA) samples. Veracyte Inc....
...South San Francisco, Calif. Anthem Inc. (NYSE:ANTM), Indianapolis, Ind. Business: Diagnostic Shannon Lehnbeuter Afirma Gene Expression Classifier Anthem Inc. Veracyte Inc....
BioCentury | Mar 2, 2017
Company News

Management tracks

...of Chelsea Therapeutics International Ltd. , which H. Lundbeck A/S (CSE:LUN) acquired. Genomic diagnostics company Veracyte Inc....
BioCentury | Jan 6, 2017
Finance

Good riddance

...NYSE-M:SYN) (A) 11/15/16 $25.0 NA $89.1 NA Tesaro Inc. (NASDAQ:TSRO) 11/15/16 $236.3 $7,210.7 $7,182.9 0% Veracyte Inc....
BioCentury | Nov 4, 2016
Financial News

Veracyte completes follow-on

...in a follow-on underwritten by Leerink Partners and BTIG. Veracyte Inc. (NASDAQ:VCYT), South San Francisco, Calif. Alicia Parker Veracyte Inc....
BioCentury | Nov 2, 2016
Financial News

Veracyte raises $30M in follow-on

...Molecular diagnostics company Veracyte Inc. (NASDAQ:VCYT) raised $30 million through the sale of 5 million shares at...
...in a follow-on underwritten by Leerink and BTIG. The price is a 16% discount to Veracyte's...
...a diagnostic tool for idiopathic pulmonary fibrosis (IPF). Veracyte fell $0.73 to $6.40 on Wednesday. Chris Lieu Veracyte Inc....
Items per page:
1 - 10 of 53